Details for New Drug Application (NDA): 215397
✉ Email this page to a colleague
The generic ingredient in MEDROXYPROGESTERONE ACETATE is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
Summary for 215397
Tradename: | MEDROXYPROGESTERONE ACETATE |
Applicant: | Amneal |
Ingredient: | medroxyprogesterone acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 215397
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MEDROXYPROGESTERONE ACETATE | medroxyprogesterone acetate | INJECTABLE;INJECTION | 215397 | ANDA | Amneal Pharmaceuticals LLC | 70121-1467 | 70121-1467-2 | 1 VIAL in 1 CARTON (70121-1467-2) / 1 mL in 1 VIAL |
MEDROXYPROGESTERONE ACETATE | medroxyprogesterone acetate | INJECTABLE;INJECTION | 215397 | ANDA | Amneal Pharmaceuticals LLC | 70121-1467 | 70121-1467-5 | 25 VIAL in 1 CARTON (70121-1467-5) / 1 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 150MG/ML | ||||
Approval Date: | Jun 7, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription